NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6
NovaBay Pharmaceuticals (NYSE American: NBY) will release its financial results for Q1 2021 on May 6, 2021, after market close. An investment community conference call is scheduled for the same day at 4:30 p.m. ET. Participants can pre-register online to gain immediate access, or dial in for live access. A replay will be available post-call until May 27, 2021. NovaBay is known for its innovative anti-infective consumer products, including Avenova, CelleRx, and NeutroPhase, utilizing a patented pharmaceutical-grade hypochlorous acid.
- Scheduled financial results for Q1 2021 may indicate transparency and investor engagement.
- Conference call allows for real-time investor feedback and discussion.
- None.
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three months ended March 31, 2021 after market close on Thursday, May 6, 2021 and will hold an investment community conference call that day at 4:30 p.m. Eastern time.
Date/Time: |
Thursday, May 6, 4:30 p.m. ET / 1:30 p.m. PT |
|
|
|
|
Pre-Registration: |
Participants can pre-register for the conference call here: |
|
|
||
|
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. |
|
|
||
Dial In: |
Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call: |
|
|
866-777-2509 from within the U.S. |
|
|
412-317-5413 from outside the U.S. |
The live webcast of the conference call also will be available at http://novabay.com/investors/events. A replay of the call will be available beginning two hours after its completion through May 27, 2021 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 10155343. The webcast will also be archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray, CelleRx® Clinical Reset™, a breakthrough product in the beauty category, and NeutroPhase® Skin and Wound Cleanser for wound healing. NovaBay’s products are formulated with its patented, pure, stable, pharmaceutical-grade hypochlorous acid that replicates the antimicrobial chemicals used by white blood cells to fight infection. NovaBay’s hypochlorous acid products do not cause stinging or irritation, are non-toxic and non-sensitizing, making them completely safe for regular use. Avenova is the only commercial hypochlorous acid lid and lash spray product clinically proven to reduce bacterial load on ocular skin surfaces, thus effectively addressing the underlying cause of bacterial dry eye.
Socialize and Stay informed on NovaBay’s progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website
Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com.
Avenova.com
CelleRx Clinical Reset Purchasing Information
For NovaBay CelleRx Clinical Reset purchasing information
Please call 877-CELLERX
www.CelleRx.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005011/en/
FAQ
When will NovaBay report its financial results for Q1 2021?
What time is the NovaBay conference call scheduled?
How can I participate in the NovaBay conference call?
What is NovaBay known for?
What is the stock symbol for NovaBay Pharmaceuticals?
